Steroid drug purchased for COVID-19 patients in poor countries: UN
Dexamethasone, the steroid drug used on Covid-19 patient.
An initial purchase of the steroid dexamethasone, shown to be effective in treating severe or critical COVID-19 patients, will be made for up to 4.5 million people in low- and middle-income countries, agencies said on Friday.
The U.N. Children's Fund (UNICEF) is negotiating the advance purchase under the deal led by UNITAID and Wellcome, as part of the World Health Organization's plan to accelerate access to therapeutics, a joint statement said.
READ MORE
How risky is flying during the coronavirus pandemic
What is PCOS? How to combat it in the lockdown
"With this advanced purchase we aim to ensure equitable access for low- and middle-income countries for treatment of COVID-19 with the life-saving drug dexamethasone, and avoid shortages resulting from high-levels of demand from other parts of the world," said Philippe Duneton, acting executive director of UNITAID.
Reuters
